Global Heart Valves Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 219 pages | ID: G1EF1098703EN
Precision Business Insights (PBI)

Abstracts

Heart valves are the medical devices which are used in the replacement of defective heart valve. Heart valves are majorly 2 types, they are biological or tissue and mechanical heart valves. Biological heart valves are made up of various tissues such as porcine, bovine and human tissues. Heart valves made from human tissues are known as homografts or allografts. The major advantage of tissue valves over mechanical valve is mechanical heart valves can cause bleeding and increase the chances of reoperations in geriatric people. Since the use of tissue heart valves in people of this age group lowers the risks of bleeding. Physicians are increasingly opting for this method as it able to reduce the use of oral anticoagulation drugs for the management of bleeding complications.

The heart valves market is growing at a significant CAGR due to increase in geriatric population, and increase in the prevalence of heart valve diseases. The increase in demand for stentless tissue valves, implementation of MI procedures expected to fuel the growth of Heart valves market. Rising in preference for tissue heart valve replacement surgeries among the geriatric population is also boosting the growth of Heart valves market over the forecast period. However, lack of skilled professional, the risk of potential complications with tissue valves, and use of alternate products might hamper the growth of Heart valves market over the forecast period. Similarly, the stringent regulatory framework for product approvals expected to dampen the growth of Heart valves market.

The heart valves market is segmented on the basis of product type, valve type, harvesting type, and end users

Based on product type, heart valves market has been segmented into the following:

• Stented tissue heart valves
• Stentless tissue heart valves

Based on valve type, heart valves market has been segmented into the following:

• Aortic tissue valves
• Mitral tissue valves

Based on the harvesting, heart valves market has been segmented into the following:

• Autograft
• Homograft
• Heterograft

Based on end-user, heart valves market has been segmented into the following:

• Hospitals
• Clinics
• Ambulatory surgical centers

Global heart valves market is increasing due to rise in the prevalence of cardiac disorders. The most commonly adopted strategies by industry players include new product launches with technological innovations, acquisitions & mergers, agreements, and collaborations to capture significant Heart valves market share. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. Acquisition of other companies allows vendors access to the product portfolio of the acquired company. For instance, in December 2012, Edwards Lifesciences Corporation and Cook Biotech Incorporated, have collaborated into a technology licensing and supply agreements for the development of tissue-engineered heart valves and related cardiovascular implants.

Geographically, heart valves market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to hold a dominant share in Heart valves market owing to increase in the prevalence of heart valve diseases, increasing research and development, favourable medical reimbursement policies increase the growth of Heart valves market in North America. Europe region holds second largest share attributed to increases in the prevalence of heart valve diseases because of changing lifestyle. Increasing government funding for R&D, technological advancements are expected to boost the growth of Heart valves market. Asia-pacific region is expected to hold the large share in forecast period due to increase in awareness regarding tissue valves, increasing geriatric population and rising opportunities in medical tourism.

Some of the players in the heart valves market are Edwards Lifesciences Corporation (U.S.), LivaNova PLC (U.K.), Medtronic (U.S.), St. Jude Medical (Abbott Laboratories) (U.S.), Braile Biomédica (Brazil), CryoLife, Inc. (U.S.), and Laboratory Corporation of America (U.S.) to name a few.

In January 2016, CryoLife, Inc. announced that it has completed its acquisition of On-X Life Technologies Holdings, Inc

In July 2014, Sorin Group, received U.S. Food and Drug Administration (FDA) approval for the Solo Smart Aortic Pericardial Heart Valve

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL HEART VALVES MARKET INTRODUCTION

2.1. Global Heart Valves Market– Taxonomy
2.2. Global Heart Valves Market–Definitions
  2.2.1. End User
  2.2.2. Product Type

3. GLOBAL HEART VALVES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Heart Valves Market Dynamics – Factors Impact Analysis
3.6. Global Heart Valves Market– Recent Market Introductions

4. GLOBAL HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL HEART VALVES MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Stented Tissue Heart Valves
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Stentless Tissue Heart Valves
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL HEART VALVES MARKET FORECAST, BY VALVE TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Aortic Tissue Valves
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Mitral Tissue Valves
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis

7. GLOBAL HEART VALVES MARKET FORECAST, BY HARVESTING, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Autograft
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Homograft
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Heterograft
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL HEART VALVES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Clinics
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis

9. GLOBAL HEART VALVES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, By End User, and Region, 2017 – 2023

10. NORTH AMERICA HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.1.1. Stented Tissue Heart Valves
    10.1.1.2. Stentless Tissue Heart Valves
  10.1.2. Valve Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Aortic Tissue Valves
    10.1.2.2. Mitral Tissue Valves
  10.1.3. Harvesting Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Autograft
    10.1.3.2. Homograft
    10.1.3.3. Heterograft
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Hospitals
    10.1.4.2. Clinics
    10.1.4.3. Ambulatory surgical centers
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, By End User, and Country, 2017 – 2023
  10.1.7. North America Heart Valves Market Dynamics – Trends

11. EUROPE HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.1.1. Stented Tissue Heart Valves
    11.1.1.2. Stentless Tissue Heart Valves
  11.1.2. Valve Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Aortic Tissue Valves
    11.1.2.2. Mitral Tissue Valves
  11.1.3. Harvesting Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Autograft
    11.1.3.2. Homograft
    11.1.3.3. Heterograft
  11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Hospitals
    11.1.4.2. Clinics
    11.1.4.3. Ambulatory surgical centers
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, By End User, and Country, 2017 – 2023
  11.1.7. Europe Heart Valves Market Dynamics – Trends

12. ASIA-PACIFIC HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.1.1. Stented Tissue Heart Valves
    12.1.1.2. Stentless Tissue Heart Valves
  12.1.2. Valve Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Aortic Tissue Valves
    12.1.2.2. Mitral Tissue Valves
  12.1.3. Harvesting Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Autograft
    12.1.3.2. Homograft
    12.1.3.3. Heterograft
  12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Hospitals
    12.1.4.2. Clinics
    12.1.4.3. Ambulatory surgical centers
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, By End User, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Heart Valves Market Dynamics – Trends

13. LATIN AMERICA HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.1.1. Stented Tissue Heart Valves
    13.1.1.2. Stentless Tissue Heart Valves
  13.1.2. Valve Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Aortic Tissue Valves
    13.1.2.2. Mitral Tissue Valves
  13.1.3. Harvesting Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Autograft
    13.1.3.2. Homograft
    13.1.3.3. Heterograft
  13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Hospitals
    13.1.4.2. Clinics
    13.1.4.3. Ambulatory surgical centers
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, End User, and Country, 2017 – 2023
  13.1.7. Latin America Heart Valves Market Dynamics – Trends

14. MIDDLE EAST & AFRICA HEART VALVES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.1.1. Stented Tissue Heart Valves
    14.1.1.2. Stentless Tissue Heart Valves
  14.1.2. Valve Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Aortic Tissue Valves
    14.1.2.2. Mitral Tissue Valves
  14.1.3. Harvesting Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Autograft
    14.1.3.2. Homograft
    14.1.3.3. Heterograft
  14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Hospitals
    14.1.4.2. Clinics
    14.1.4.3. Ambulatory Surgical Centers
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Heart Valves Market- Opportunity Analysis Index - By Product Type, By Valve Type, By Harvesting, By End User, and Country, 2017 – 2023
  14.1.7. MEA Heart Valves Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Edwards Lifesciences Corporation (U.S.)
  15.2.2. LivaNova PLC (U.K.)
  15.2.3. Medtronic (U.S.)
  15.2.4. St. Jude Medical (Abbott Laboratories) (U.S.)
  15.2.5. Braile Biomédica (Brazil)
  15.2.6. CryoLife, Inc. (U.S.)
  15.2.7. Laboratory Corporation of America (U.S.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS